Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
FTH compared with DBVT: revenue, margins and what each company keeps, and the suppliers and customers both name
FTH
Faeth Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
DBVT
DBV Technologies S.A.
Change
Mkt cap
Revenue
Revenue
vs
Compare
FTH
Faeth Therapeutics, Inc.
vs
DBVT
DBV Technologies S.A.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
FTH, solid
DBVT, dashed
Supply-chain overlap
Revenue flow
FTH: latest quarter not drawable. DBVT: latest quarter is a loss; flow not drawable.
Method
›
FTH
Faeth Therapeutics, Inc.
Change
18.21
▼
−2.89%
· post 18.32
Mkt cap
$483.0M
Revenue
—
Revenue
—
DBVT
DBV Technologies S.A.
Change
9.45
▼
−8.13%
· post 9.45
Closed
Oct 30 '26
Mkt cap
$596.7M
Revenue
$2M
Q3 FY26
Revenue
$6M
FY25
vs
Compare
Closed
Oct 30 '26
FTH
Faeth Therapeutics, Inc.
vs
DBVT
DBV Technologies S.A.
18.21
▼
−2.89%
post 18.32
Price
9.45
▼
−8.13%
post 9.45
$483.0M
Mkt cap
$596.7M
—
Revenue
$2M
Q3 FY26
—
Revenue
$6M
FY25
Change
Change
FTH
18.21
▼
−2.89%
vs
DBVT
9.45
▼
−8.13%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only FTH
2
TAK
Takeda Pharmaceutical
supplier
—
The Regents of the University of California
unlisted
supplier
Shared
0
No shared counterparties.
Only DBVT
1
SNY
Sanofi
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR